Published in Eur Respir J Suppl on September 01, 2002
IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res (2006) 2.66
N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD. Respir Res (2009) 1.50
Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc (2007) 1.49
Fiber-optic microsphere-based antibody array for the analysis of inflammatory cytokines in saliva. Anal Chem (2009) 1.35
Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir Res (2005) 1.25
High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med (2011) 1.19
Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling. J Clin Microbiol (2009) 1.13
Air pollution related prothrombotic changes in persons with diabetes. Environ Health Perspect (2010) 1.11
Evaluation of lung flute in sputum samples for molecular analysis of lung cancer. Clin Transl Med (2013) 1.09
Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations. Lung India (2015) 1.07
Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma. PLoS One (2014) 1.05
Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives. Int J Chron Obstruct Pulmon Dis (2008) 1.00
Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls. Int J Chron Obstruct Pulmon Dis (2015) 0.96
Characterisation of asthma that develops during adolescence; findings from the Isle of Wight Birth Cohort. Respir Med (2011) 0.89
Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators Inflamm (2011) 0.89
Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma. BMC Pulm Med (2011) 0.88
Sputum analysis in diagnosis and management of obstructive airway diseases. Ther Clin Risk Manag (2005) 0.85
Safety and tolerability of sputum induction in adolescents and adults with suspected pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis (2011) 0.85
Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD. Respir Res (2010) 0.85
A controlled trial of sputum induction and routine collection methods for TB diagnosis in a South African community. Eur J Clin Microbiol Infect Dis (2014) 0.85
DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach. Br J Cancer (2015) 0.85
Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum. Respir Res (2009) 0.84
Increased heat shock protein 70 levels in induced sputum and plasma correlate with severity of asthma patients. Cell Stress Chaperones (2011) 0.84
Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers. BMC Pulm Med (2014) 0.83
Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients. Respir Res (2014) 0.83
Capsaicin cough sensitivity is related to the older female predominant feature in chronic cough patients. Allergy Asthma Immunol Res (2014) 0.83
Multiplexed salivary protein profiling for patients with respiratory diseases using fiber-optic bundles and fluorescent antibody-based microarrays. Anal Chem (2013) 0.82
Chronic cough and laryngeal dysfunction improve with specific treatment of cough and paradoxical vocal fold movement. Cough (2009) 0.82
The role of induced sputum in the diagnosis of pulmonary tuberculosis. Lung India (2013) 0.81
Comparison of 4 AM and 4 PM bronchial responsiveness to hypertonic saline in asthma. Lung (2006) 0.81
Depressiveness, symptoms of anxiety and cognitive dysfunctions in patients with asthma and chronic obstructive pulmonary disease (COPD): possible associations with inflammation markers: a pilot study. J Neural Transm (Vienna) (2014) 0.81
Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues. Front Pharmacol (2011) 0.79
Long-term home noninvasive mechanical ventilation increases systemic inflammatory response in chronic obstructive pulmonary disease: a prospective observational study. Mediators Inflamm (2014) 0.79
Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.79
Efficacy of add-on montelukast in nonasthmatic eosinophilic bronchitis: the additive effect on airway inflammation, cough and life quality. Chin Med J (Engl) (2015) 0.79
Pathophysiological characterization of asthma transitions across adolescence. Respir Res (2014) 0.79
Noninvasive effects measurements for air pollution human studies: methods, analysis, and implications. J Expo Sci Environ Epidemiol (2015) 0.79
Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study. Respir Res (2007) 0.78
Efficacy of Induced Sputum for the Diagnosis of Pulmonary Tuberculosis in Adults Unable to Expectorate Sputum. Tuberc Respir Dis (Seoul) (2015) 0.77
Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis Bronchiectasis. Mediators Inflamm (2015) 0.77
Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls. Int J Chron Obstruct Pulmon Dis (2016) 0.77
Oropharyngeal and Sputum Microbiomes Are Similar Following Exacerbation of Chronic Obstructive Pulmonary Disease. Front Microbiol (2017) 0.76
Fibrosis biomarkers in workers exposed to MWCNTs. Toxicol Appl Pharmacol (2016) 0.76
Sputum eosinophilia is a determinant of FEV1 decline in occupational asthma: results of an observational study. BMJ Open (2015) 0.76
Microbial yield from physiotherapy assisted sputum production in respiratory outpatients. BMC Pulm Med (2016) 0.76
Serum Vitamin A and Inflammatory Markers in Individuals with and without Chronic Obstructive Pulmonary Disease. Mediators Inflamm (2015) 0.75
Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma. PLoS One (2016) 0.75
Chronic rhinosinusitis is associated with higher prevalence and severity of bronchiectasis in patients with COPD. Int J Chron Obstruct Pulmon Dis (2017) 0.75
CXC chemokine superfamily induced by Interferon-γ in asthma: a cross-sectional observational study. Asthma Res Pract (2016) 0.75
Correlations of salivary biomarkers with clinical assessments in patients with cystic fibrosis. PLoS One (2015) 0.75
Expression of toll-like receptors 2 and 4 in subjects with asthma by total serum IgE level. Respir Res (2016) 0.75
A Systemic Inflammatory Endotype of Asthma With More Severe Disease Identified by Unbiased Clustering of the Serum Cytokine Profile. Medicine (Baltimore) (2016) 0.75
The Cell-CT 3-dimensional cell imaging technology platform enables the detection of lung cancer using the noninvasive LuCED sputum test. Cancer Cytopathol (2015) 0.75
The Emerging Role of The Eosinophil and Its Measurement in Chronic Cough. Open Respir Med J (2017) 0.75
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 9.44
Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet (1994) 4.77
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.69
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med (1999) 3.22
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med (1998) 3.22
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med (1994) 3.06
Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J (2005) 3.05
Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J (2010) 2.77
[Hyperventilation: not a cause of panic attacks]. Ned Tijdschr Geneeskd (1993) 2.64
Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med (1998) 2.62
Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.58
Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med (1992) 2.52
Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax (1996) 2.52
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 2.52
Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47
Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36
Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J (2007) 2.16
The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med (2000) 2.07
Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J (1996) 2.05
Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis (1993) 2.02
Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax (2005) 1.99
Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1. Eur Respir J (2004) 1.95
Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol (1993) 1.94
Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 1.91
Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax (2004) 1.89
Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med (2001) 1.88
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med (1997) 1.79
Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J (2002) 1.79
Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma. Thorax (2001) 1.76
Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy (1997) 1.76
Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells. Thorax (2009) 1.74
Circulating catecholamines in acute asthma. Br Med J (Clin Res Ed) (1985) 1.73
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer. Eur Respir J (2007) 1.73
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy (1996) 1.72
Rhinosinusitis in severe asthma. J Allergy Clin Immunol (2001) 1.72
Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J (2004) 1.70
Standardised methodology of sputum induction and processing. Eur Respir J Suppl (2002) 1.70
Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med (1998) 1.69
Frequent exacerbators--a distinct phenotype of severe asthma. Clin Exp Allergy (2014) 1.69
Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol (1999) 1.68
Iatrogenic eosinophilic pleural effusion. Eur Respir Rev (2011) 1.63
Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax (2005) 1.60
Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy (2005) 1.59
Comparison of two methods of processing induced sputum: selected versus entire sputum. Am J Respir Crit Care Med (1998) 1.56
A novel double-isotope technique for the enzymatic assay of plasma histamine: application to estimation of mast cell activation assessed by antigen challenge in asthmatics. J Allergy Clin Immunol (1982) 1.56
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy (2012) 1.55
Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med (1995) 1.55
Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med (1997) 1.55
Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol (1997) 1.53
The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy (1999) 1.52
Physical properties of aerosols produced by several jet- and ultrasonic nebulizers. Bull Eur Physiopathol Respir (1984) 1.52
Update on severe asthma: what we know and what we need. Eur Respir Rev (2009) 1.50
Murine models of asthma. Eur Respir J (2003) 1.49
Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med (2001) 1.46
Measurement of plasma histamine in asthma. Clin Allergy (1983) 1.46
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45
Effect of long-term beta2-agonist dosing on human cardiac beta-adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte beta-receptors. J Nucl Cardiol (1998) 1.45
Compliance in asthma. Respir Med (1999) 1.44
Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. Am J Respir Crit Care Med (1996) 1.44
Lung sounds during allergen-induced asthmatic responses in patients with asthma. Am J Respir Crit Care Med (1996) 1.42
Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients. Thorax (2001) 1.41
Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma. Clin Pharmacol Ther (2011) 1.41
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med (2000) 1.40
[Adult asthma exacerbations in questions]. Rev Mal Respir (2010) 1.40
[COPD and inflammation: statement from a French expert group: inflammation and remodelling mechanisms]. Rev Mal Respir (2010) 1.40
Occurrence of a late response to exercise in asthmatic children: multiple regression approach using time-matched baseline and histamine control days. Eur Respir J (1996) 1.40
[Analysis of induced sputum in the management of asthma: a valid technique, a service rendered by community pneumonologists]. Rev Mal Respir (2002) 1.38
[Thrombocytopenia induced by rifampicin not previously sensitized: a case presentation]. Rev Mal Respir (2013) 1.38
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl (2002) 1.36
The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. Am J Respir Crit Care Med (2000) 1.36
Induced sputum to assess airway inflammation: a study of reproducibility. Clin Exp Allergy (1997) 1.35
Increased activation of p38 MAPK in COPD. Eur Respir J (2007) 1.33
Inhaled sodium metabisulphite induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol (1990) 1.33
Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis (1992) 1.31
Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy (2008) 1.31
Asthma: a disease remodeling the airways. Allergy (1992) 1.30
Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med (1996) 1.28
Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J (2003) 1.27
Neutrophils in chronic inflammatory airway diseases: can we target them and how? Eur Respir J (2010) 1.27
Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex. Br J Pharmacol (1986) 1.27
HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis (1993) 1.26
Chest radiography and high resolution computed tomography of the lungs in asthma. Am Rev Respir Dis (1992) 1.26
The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol (1995) 1.26
The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin Exp Allergy (2003) 1.25
Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am J Pathol (1997) 1.25
Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med (1999) 1.25
Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax (1992) 1.23
Safety of sputum induction. Eur Respir J Suppl (2002) 1.23
Are overweight asthmatics more difficult to control? Allergy (2006) 1.22
Defensins: key players or bystanders in infection, injury, and repair in the lung? J Allergy Clin Immunol (1999) 1.21